Digestive Diseases and Sciences

, Volume 56, Issue 6, pp 1612–1618 | Cite as

Methane on Breath Testing Is Associated with Constipation: A Systematic Review and Meta-analysis

  • David Kunkel
  • Robert J. Basseri
  • Marc D. Makhani
  • Kelly Chong
  • Christopher Chang
  • Mark Pimentel
Original Article

Abstract

Background

A growing body of literature suggests an association between methane and constipation. Studies also link degree of methane production to severity of constipation and have shown constipation is improved following antibiotics.

Aims

We aim to conduct a systematic review and meta-analysis to examine the cumulative evidence regarding the association between methane and constipation.

Methods

A literature search was performed using MEDLINE and Embase to identify studies where the presence (or absence) of methane was assessed in constipated subjects. Search terms included “methane,” “breath test,” “constipation,” “motility,” “transit,” “irritable bowel syndrome” and/or “IBS.” Pooled odds ratios were generated using a random effects model. In a separate analysis, studies that measured intestinal transit in methane and non-methane subjects were systematically reviewed.

Results

Nine studies met inclusion criteria for the meta-analysis. Among these, 1,277 subjects were examined by breath testing (N = 319 methane producers and N = 958 methane non-producers). Pooling all studies, a significant association was found between methane on breath test and constipation (OR = 3.51, CI = 2.00–6.16). Among adults only, methane was significantly associated with constipation (OR = 3.47, CI = 1.84–6.54). Similar results were seen when only examining subjects with IBS (OR = 3.60, CI = 1.61–8.06). The systematic review identified eight additional papers which all demonstrated an association between methane and delayed transit.

Conclusions

We demonstrate that methane present on breath testing is significantly associated with constipation in both IBS and functional constipation. These results suggest there may be merit in using breath testing in constipation. Moreover, methane may be used to identify candidates for antibiotic treatment of constipation.

Keywords

Methane Breath test Transit Constipation 

Notes

Acknowledgments

We would like to thank the Beatrice and Samuel A. Seaver Foundation for their ongoing support of our research in the GI Motility Program at Cedars-Sinai Medical Center.

Conflict of interest

There are no commercial associations that might pose or create a conflict of interest with information presented in this submitted manuscript such as consultancies, stock ownership, or patent licensing arrangements. All sources of funds supporting the completion of this manuscript are under the auspices of the Cedars-Sinai Medical Center.

References

  1. 1.
    Palmer C, Bik EM, DiGiulio DB, et al. Development of the human infant intestinal microbiota. PLoS Biol. 2007;5:e177.PubMedCrossRefGoogle Scholar
  2. 2.
    Berg RD. The indigenous gastrointestinal microflora. Trends Microbiol. 1996;4:430–435.PubMedCrossRefGoogle Scholar
  3. 3.
    Gorbach SL. Intestinal microflora. Gastroenterology. 1971;60:1110–1129.PubMedGoogle Scholar
  4. 4.
    Mackie RI, Sghir A, Gaskins HR. Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr. 1999;69:1035S–1045S.PubMedGoogle Scholar
  5. 5.
    Ley RE, Turnbaugh PJ, Klein S, et al. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444:1022–1023.PubMedCrossRefGoogle Scholar
  6. 6.
    Zoetendal E, Akkermans A, Akkermans-van Vliet W, et al. The host genotype affects the bacterial community in the human gastrointestinal tract. Microb Ecol Health Dis. 2001;13:129–134.CrossRefGoogle Scholar
  7. 7.
    Hopkins MJ, Sharp R, MacFarlane GT. Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut. 2001;48:198–205.PubMedCrossRefGoogle Scholar
  8. 8.
    Gill SR, Pop M, DeBoy RT, et al. Metagenomic analysis of the human distal gut microbiome. Science. 2006;312:1355–1359.PubMedCrossRefGoogle Scholar
  9. 9.
    Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science. 2005;308:1635–1638.PubMedCrossRefGoogle Scholar
  10. 10.
    Macfarlane S, Macfarlane GT. Bacterial diversity in the human gut. Adv Appl Microbiol. 2004;54:261–289.PubMedCrossRefGoogle Scholar
  11. 11.
    Manning AP, Thompson WG, Heaton KW, et al. Towards positive diagnosis of the irritable bowel. BMJ. 1978;2:653–654.PubMedCrossRefGoogle Scholar
  12. 12.
    Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology. 2006;130:1480–1491.PubMedCrossRefGoogle Scholar
  13. 13.
    Wilson S, Roberts L, Roalfe A, et al. Prevalence of irritable bowel syndrome: a community survey. Br J Gen Pract. 2004;54:495–502.PubMedGoogle Scholar
  14. 14.
    Gwee KA, Wee S, Wong ML, Png DJ. The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an Asian urban community. Am J Gastroenterol. 2004;99:924–931.PubMedCrossRefGoogle Scholar
  15. 15.
    Hungin AP, Chang L, Locke GR, Dennis EH, Barghout V. Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment Pharmacol Ther. 2005;21:1365–1375.PubMedCrossRefGoogle Scholar
  16. 16.
    Rome Foundation. Guidelines—Rome III diagnostic criteria for functional gastrointestinal disorders. J Gastrointestin Liver Dis. 2006;15:301–312.Google Scholar
  17. 17.
    Levitt MD, Bond JH. Volume, composition, and source of intestinal gas. Gastroenterology. 1970;59:921–929.PubMedGoogle Scholar
  18. 18.
    Macfarlane GT, Macfarlane S. Human colonic microbiota: ecology, physiology and metabolic potential of intestinal bacteria. Scand J Gastroenterol Suppl. 1997;222:3–9.PubMedGoogle Scholar
  19. 19.
    Weaver GA, Krause JA, Miller TL, et al. Incidence of methanogenic bacteria in a sigmoidoscopy population: an association of methanogenic bacteria and diverticulosis. Gut. 1986;27:698–704.PubMedCrossRefGoogle Scholar
  20. 20.
    Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science. 2005;308:1635–1638.PubMedCrossRefGoogle Scholar
  21. 21.
    Pimentel M, Mayer AG, Park S, Chow EJ, Hasan A, Kong Y. Methane production during lactulose breath test is associated with gastrointestinal disease presentation. Dig Dis Sci. 2003;48:86–92.PubMedCrossRefGoogle Scholar
  22. 22.
    Pimentel M, Lin HC, Enayati P, et al. Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestine contractile activity. Am J Physiol Gastrointest Liver Physiol. 2006;290:G1089–G1095.PubMedCrossRefGoogle Scholar
  23. 23.
    Hwang L, Low K, Khoshini R, et al. Evaluating breath methane as a diagnostic test for constipation-predominant IBS. Dig Dis Sci. 2010;55:398–403.PubMedCrossRefGoogle Scholar
  24. 24.
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188.PubMedCrossRefGoogle Scholar
  25. 25.
    Hulley SB, Cummings SR, Browner WS et al. Designing Clinical Research. 3rd ed. Lippincot: Williams & Wilkins; 2007:220.Google Scholar
  26. 26.
    Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Statist Med. 2004;23:1351–1375.CrossRefGoogle Scholar
  27. 27.
    Harbord RM, Egger M, Sterne JAC. A modified test for small-study effects in meta-analysis of controlled clinical trials with binary endpoints. Stat Med. 2006;25:3443–3457.PubMedCrossRefGoogle Scholar
  28. 28.
    Peled Y, Weinberg D, Hallak A, Gilat T. Factors affecting methane production in humans. Gastrointestinal diseases and alterations of colonic flora. Dig Dis Sci. 1987;32:267–271.PubMedCrossRefGoogle Scholar
  29. 29.
    Fiedorek SC, Pumphrey CL, Casteel HB. Breath methane production in children with constipation and encopresis. J Pediatr Gastroenterol Nutr. 1990;10:473–477.PubMedCrossRefGoogle Scholar
  30. 30.
    Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. A double-blind, randomized, placebo-controlled study. Am J Gastroenterol. 2003;98:412–419.PubMedGoogle Scholar
  31. 31.
    Majewski M, McCallum RW. Results of small intestinal bacterial overgrowth testing in irritable bowel syndrome patients: clinical profiles and effects of antibiotic trial. Adv Med Sci. 2007;52:139–142.PubMedGoogle Scholar
  32. 32.
    Bratten JR, Spanier J, Jones MP. Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls. Am J Gastroenterol. 2008;103:958–963.PubMedCrossRefGoogle Scholar
  33. 33.
    Parodi A, Dulbecco P, Savarino E, et al. Positive glucose breath testing is more prevalent in patients with IBS-like symptoms compared with controls of similar age and gender distribution. J Clin Gastroenterol. 2009;43:962–966.PubMedCrossRefGoogle Scholar
  34. 34.
    Attaluri A, Jackson M, Valestin J, Rao SS. Methanogenic flora is associated with altered colonic transit but not stool characteristics in constipation without IBS. Am J Gastroenterol. 2009;105:1407–1411.PubMedCrossRefGoogle Scholar
  35. 35.
    Rana SV, Sinha SK, Sharma S, Kaur H, Bhasin DK, Singh K. Effect of predominant methanogenic flora on outcome of lactose hydrogen breath test in controls and irritable bowel syndrome patients of north India. Dig Dis Sci. 2009;54:1550–1554.PubMedCrossRefGoogle Scholar
  36. 36.
    Soares AC, Tahan S, Fagundes-Neto U, de Morais MB. Breath methane in children with chronic constipation. Arq Gastroenterol. 2002;39:66–72.PubMedCrossRefGoogle Scholar
  37. 37.
    Grover M, Kanazawa M, Palsson OS, et al. Small intestinal bacterial overgrowth in irritable bowel syndrome: association with colon motility, bowel symptoms, and psychological distress. Neurogastroenterol Motil. 2008;20:998–1008.PubMedCrossRefGoogle Scholar
  38. 38.
    Kajs TM, Fitzgerald JA, Buckner RY, et al. Influence of a methanogenic flora on the breath H2 and symptom response to ingestion of sorbitol or oat fiber. Am J Gastroenterol. 1997;92:89–94.PubMedGoogle Scholar
  39. 39.
    Stephen AM, Wiggins HS, Englyst HN, Cole TJ, Wayman BJ, Cummings JH. The effect of age, sex and level of intake of dietary fibre from wheat on large-bowel function in thirty healthy subjects. Br J Nutr. 1986;56:349–361.PubMedCrossRefGoogle Scholar
  40. 40.
    Cloarec D, Bornet F, Gouilloud S, Barry JL, Salim B, Galmiche JP. Breath hydrogen response to lactulose in healthy subjects: relationship to methane producing status. Gut. 1990;31:300–304.PubMedCrossRefGoogle Scholar
  41. 41.
    Rumessen JJ, Nordgaard-Andersen I, Gudmand-Høyer E. Carbohydrate malabsorption: quantification by methane and hydrogen breath tests. Scand J Gastroenterol. 1994;29:826–832.PubMedCrossRefGoogle Scholar
  42. 42.
    Oufir LE, Barry JL, Flourié B, et al. Relationships between transit time in man and in vitro fermentation of dietary fiber by fecal bacteria. Eur J Clin Nutr. 2000;54:603–609.PubMedCrossRefGoogle Scholar
  43. 43.
    Soares AC, Lederman HM, Fagundes-Neto U, de Morais MB. Breath methane associated with slow colonic transit time in children with chronic constipation. J Clin Gastroenterol. 2005;39:512–515.PubMedCrossRefGoogle Scholar
  44. 44.
    Levitt MD, Furne JK, Kuskowski M, Ruddy J. Stability of human methanogenic flora over 35 years and a review of insights obtained from breath methane measurements. Clin Gastroenterol Hepatol. 2006;4:123–129.PubMedCrossRefGoogle Scholar
  45. 45.
    Morken MH, Berstad AE, Nysaeter G, Berstad A. Intestinal gas in plain abdominal radiographs does not correlate with symptoms after lactulose challenge. Eur J Gastroenterol Hepatol. 2007;19:589–593.PubMedCrossRefGoogle Scholar
  46. 46.
    Chatterjee S, Park S, Low K, Kong Y, Pimentel M. The degree of breath methane production in IBS correlates with the severity of constipation. Am J Gastroenterol. 2007;102:837–841.PubMedCrossRefGoogle Scholar
  47. 47.
    Shah ED, Basseri RJ, Chong K, Pimentel M. Abnormal breath testing in IBS: a meta-analysis. Dig Dis Sci. 2010;55:2441–2449.PubMedCrossRefGoogle Scholar
  48. 48.
    Posserud I, Stotzer PO, Björnsson ES, Abrahamsson H, Simrén M. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut. 2007;56:802–808.PubMedCrossRefGoogle Scholar
  49. 49.
    Pimentel M, Park S, Mirocha J, et al. The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome. Ann Intern Med. 2006;145:557–563.PubMedGoogle Scholar
  50. 50.
    Sharara AI, Aoun E, Abdul-Baki H, et al. A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence. Am J Gastroenterol. 2006;101:326–333.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • David Kunkel
    • 1
  • Robert J. Basseri
    • 1
  • Marc D. Makhani
    • 1
  • Kelly Chong
    • 2
  • Christopher Chang
    • 1
  • Mark Pimentel
    • 1
  1. 1.GI Motility ProgramCedars-Sinai Medical CenterLos AngelesUSA
  2. 2.Division of General Internal Medicine and Health Services ResearchUCLA Department of MedicineLos AngelesUSA

Personalised recommendations